Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion

Medical Science Monitor

Volumn 15, Issue 9, 2009, Pages

  Naji, Franjo ^a   Suran, David ^a   Kanic, Vojko ^a   Vokac, Damijan ^a   Sabovic, Miso ^b  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Amiodarone; Atrial fibrillation; Electrical cardioversion; Statins

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ADULT; ANTICOAGULATION; ARTICLE; CARDIOVERSION; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE DURATION; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SIDE EFFECT; SINUS RHYTHM;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70349923639     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Engelmann MD, Svendsen JH: Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J, 2005; 26: 2083-2092 (Pubitemid 41408600)
2. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA: The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol, 2007; 115: 135-143 (Pubitemid 46136515)
3. Kostapanos MS, Liberopoulos EN, Goudevenos JA et al: Do statins have an antiarrhythmic activity? Cardiovasc Res, 2007; 75: 10-20
4. Siu CW, Lau CP, Tse HF: Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol, 2003; 92: 1343-1345 (Pubitemid 37431149)
5. Ozaydin M, Varol E, Aslan SM et al: Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. Am J Cardiol, 2006; 97: 1490-1493
6. Tveit A, Grundtvig M, Gundersen T et al: Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol, 2004; 93: 780-782 (Pubitemid 38338579)
7. Patti G, Chello M, Candura D et al: Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After cardiac surgery) study. Circulation, 2006; 114: 1455-1461 (Pubitemid 44526999)
8. Humphries KH, Lee M, Sheldon R et al: Statin use and recurrence of atrial fibrillation after successful cardioversion. Am Heart J, 2007; 154: 908-913 (Pubitemid 350010927)
9. Capucci A, Villani GQ, Aschieri D et al: Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J, 2000; 21: 66-73 (Pubitemid 30042671)
10. Lafuente-Lafuente C, Mouly S, Longás-Tejero MA et al: Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. Arch Intern Med, 2006; 166: 719-728
11. Casaclang-Verzosa G, Gersh BJ, Tsang TS: Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol, 2008; 51: 1-11
12. Strandberg TE,Vanhanen H, Tikkanen MJ: Effect of statins on C-reactive protein in patients with coronary artery disease. Lancet, 1999; 353: 118-119 (Pubitemid 29088085)
13. Rosenson RS: Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis, 2004; 173: 1-12
14. Dupuis J, Tardif JC, Cernacek P, Theroux P: Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (REduction of Cholesterol in Ischemia and Function of the Endothelium) trial. Circulation, 1999; 99: 3227-3233
15. Laufs U, La Fata V, Plutzky J, Liao JK: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation, 1998; 97: 1129-1135 (Pubitemid 28152885)
16. Sinno H, Derakhchan K, Libersan D et al: Atrial ischemia promotes atrial fibrillation in dogs. Circulation, 2003; 107: 1930-1936 (Pubitemid 36444137)
17. Wang K, Takahara A, Nakamura Y et al: In vivo electropharmacological effects of amiodarone and candesartan on atria of chronic atrioventricular block dogs. J Pharmacol Sci, 2007; 103: 207-213
18. Shinagawa K, Shiroshita-Takeshita A, Schram G, Nattel S: Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone. Circulation, 2003; 107: 1440-1446 (Pubitemid 36350745)
19. Liu T, Li L, Korantzopoulos P et al: Statin use and development of atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials and observational studies. Int J Cardiol, 2008; 126: 160-170 (Pubitemid 351602110)
20. Alsheikh-Ali AA, Karas RH: Adverse events with concomitant amiodarone and statin therapy. Prev Cardiol, 2005; 8: 95-97
21. Pasternak RC, Smith SC Jr, Bairey-Merz CN et al, American College of Cardiology; American Heart Association; National Heart, Lung and Blood Institute. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol, 2002; 40: 567-572
22. De Backer G, Ambrosioni E, Borch-Johnsen K et al: European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. European Heart Journal, 2003; 24: 1601-1610 (Pubitemid 37012194)